#USA #Aliso Viejo #Terumo Neuro #SOFIA 88 #Neurovascular Catheter

Expanding Stroke Care: Terumo Neuro Unveils the SOFIA™ 88 Catheter

In a significant advancement for stroke treatment, Terumo Neuro has announced the commercial availability of the SOFIA™ 88 Neurovascular Support Catheter. This new product marks an important addition to their existing stroke portfolio, offering clinicians the latest in neurovascular technology.

A Legacy of Innovation

As a well-established leader in neurovascular solutions, Terumo Neuro has built its reputation on 10 years of clinical performance and innovation. The SOFIA™ 88 has been designed with a focus on reliability and control, ensuring that physicians have the tools they need to deliver the best possible care. With more than 500,000 procedures performed globally over the last decade using the SOFIA catheter line, its trusted performance is evident.

What Sets the SOFIA™ 88 Apart?

The SOFIA™ 88 boasts a large-bore design, featuring an inner diameter of 0.088 inches. Its proprietary engineering enhances usability with several key benefits:

• - Reliable Trackability: Transition zones are optimized for navigating challenging anatomy, paired with a soft, atraumatic distal tip.
• - Enhanced Proximal Stability: The catheter ensures procedural ease by providing stability with both short and long sheaths, allowing physicians to work more confidently.
• - Vessel-Friendly Flexibility: Designed to minimize vessel trauma, the catheter's flexible construction supports smooth navigation through the vascular system.

Dr. Ameer Hassan, Head of the Neuroscience Department at Valley Baptist and a Professor at the University of Texas Rio Grande Valley, praised the SOFIA™ 88, stating, "It improves my access whether I use it for aspiration only or a combination approach - it really does enhance my first pass effect."

Continued Commitment to Neuroscience

The introduction of the SOFIA™ 88 Neurovascular Support Catheter underscores Terumo Neuro's ongoing investment in the field of neurovascular innovation. Carsten Schroeder, President and CEO, remarked on their dedication to enhancing stroke care, made possible through direct physician collaboration and strong research, development, and manufacturing capabilities.

This product seamlessly integrates with existing aspiration strategies, including compatibility with the SOFIA™ Flow Plus 6F Aspiration Catheter. The SOFAST registry provides clinical evidence showcasing its efficacy, safety, and speed, promoting optimal clinical outcomes.

Complementing the Stroke Solution Portfolio

The SOFIA™ 88 is part of a comprehensive suite of stroke solutions designed to address various aspects of care:

• - SOFIA™ and SOFIA™ Flow Plus Aspiration Catheters: Known for their trackability and clinical performance.
• - ERIC™ Retrieval Device: Facilitates thrombus control and enhances procedural efficiency.
• - BOBBY™ Balloon Guide Catheter: Designed for reliable flow arrest and preparation ease.
• - WEDGE™ Microcatheter: Minimizes ledge effects during navigation.
• - HEADWAY™ Microcatheters: Offers low-profile options for versatile access.
• - TRAXCESS™ Guidewires: Features a soft-tip design suitable for challenging anatomies.

About Terumo Neuro

Previously known as MicroVention, Terumo Neuro has been dedicated to developing groundbreaking innovations in neurovascular treatment since 1997. Now a wholly owned subsidiary of Terumo Corporation, the company offers over thirty products addressing cerebral aneurysms, ischemic stroke, carotid artery disease, and neurovascular malformations. With headquarters in California, Terumo Neuro’s products reach more than seventy countries worldwide.

Looking Towards the Future

As Terumo continues to expand its product offerings and innovate within the neurovascular space, the SOFIA™ 88 Catheter reflects their mission to redefine possibilities in stroke treatment, ultimately benefiting both healthcare providers and their patients. Through ongoing advancements and strategic collaborations, Terumo Neuro is committed to transforming stroke care and improving patient outcomes on a global scale.